A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This Phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study aims to assess the efficacy, safety, and PK characteristics of DA-302168S tablets in Chinese T2DM participants, and to provide dose-selection evidence for the Phase III confirmatory trial.
Epistemonikos ID: bf4c299a1cf8ce3322110e0642a5d69f48696256
First added on: Aug 11, 2026